Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Long-term safety of azathioprine therapy in multiple sclerosis.
Diagnostic value of aquaporin 4 antibody in assessing idiopathic inflammatory demyelinating central nervous system diseases in Egyptian patients.
Adiponectin Suppresses T Helper 17 Cell Differentiation and Limits Autoimmune CNS Inflammation via the SIRT1/PPARγ/RORγt Pathway.
17β-estradiol replacement therapy protects myelin sheaths in the white matter of middle-aged female ovariectomized rats: a stereological study.
Oral corticosteroids for multiple sclerosis relapse.
Evaluation of diffusion kurtosis imaging in ex vivo hypomyelinated mouse brains.
Treatment of pediatric chronic inflammatory demyelinating polyneuropathy: Challenges, controversies and questions.
Targeting the 18-kDa translocator protein: recent perspectives for neuroprotection.
Multiple sclerosis: Regenerative therapies for MS-hope on the horizon.
Btn2a2, a T cell immunomodulatory molecule coregulated with MHC class II genes.
USPIO-Enhanced MRI Neuroimaging: A Review.
Blocking mitochondrial calcium release in Schwann cells prevents demyelinating neuropathies.
Sedentary behaviour in people with multiple sclerosis: Is it time to stand up against MS?
Quantitative evaluation of cerebral white matter in patients with multiple sclerosis using multicomponent T2 mapping.
Diffusion MRI-based cortical complexity alterations associated with executive function in multiple sclerosis.
Invariant Natural Killer T-cell anergy to endogenous myelin acetyl-glycolipids in multiple sclerosis.
Decision-making in multiple sclerosis consultations in Italy: third observer and patient assessments.
Detection of protein aggregates in brain and cerebrospinal fluid derived from multiple sclerosis patients.
Transgenic replacement of Cx32 in gap junction deficient oligodendrocytes rescues the phenotype of a hypomyelinating leukodystrophy model.
Demyelinating disease: CSF analysis could aid prediction of conversion from optic neuritis to multiple sclerosis in children.
Deep grey matter involvement in multiple sclerosis: key player or bystander?
Widespread Pressure Pain Hypersensitivity in Patients with Multiple Sclerosis with and Without Pain as Sign of Central Sensitization.
The current role of mitoxantrone in the treatment of multiple sclerosis.
Adjusted Indirect Comparison of Oral Multiple Sclerosis Agents.
Pages
« first
‹ previous
…
565
566
567
568
569
570
571
572
573
…
next ›
last »